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INTRODUCTION
Since acute eosinophilic pneumonia was first described by 
Badesch
1 and Allen
2 in 1989, fewer than 150 cases have been re-
ported worldwide. Acute eosinophilic pneumonia is extremely 
rare, especially in children.
3 The current diagnostic criteria are 
as follows: fever, acute respiratory symptoms during a period of 
<1 week, diffuse bilateral infiltrates on chest X-ray, severe hypox-
ia, ≥25% eosinophilia in bronchoalveolar lavage fluid (BALF), 
or eosinophilic infiltrates in lung tissue biopsy and absence of 
definite causes of eosinophilic pneumonia such as drugs, infec-
tion, asthma, or atopy.
4,5 This disease is similar clinically to acute 
interstitial pneumonitis or acute respiratory distress syndrome; 
therefore, its treatment is apt to fail if diagnosis is delayed with-
out BALF tests. We experienced the case of a 15-year-old girl 
who recently started smoking and presented with the clinical 
and pathological features of acute eosinophilic pneumonia. To 
the best of our knowledge, this patient is the youngest among 
those reported with smoking-induced acute eosinophilic pneu-
monia in Korea. Recently, people have started smoking earlier, 
and it is difficult to obtain an accurate history of smoking. This 
is a case in which the history of smoking was inferred from the 
urine cotinine level.
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CASE REPORT
A 15-year-old girl was admitted to our hospital with a 1-week 
history of fever as well as dry cough, dyspnea, and myalgia that 
started on the day of admission. She had been healthy prior to 
admission and had no notable history of respiratory or allergic 
disease. In her family history, her father was being treated for 
liver cirrhosis. She had started smoking 3-5 cigarettes daily 3 
weeks before admission, but stopped smoking 1 week before 
admission due to discomfort after smoking. On admission, the 
patient had clear consciousness but appeared acutely ill. Her 
blood pressure was 112/70 mmHg, pulse rate 121/minute, re-
spiratory rate 24/minute, and body temperature 36.4°C. The 
conjunctivae were pink, and the sclerae showed no sign of jaun-
dice. No cervical lymph nodes were palpable. On physical ex-
amination, rales and coarse breathing sounds were audible, but 
heart sounds were normal. There were no abnormal findings in 
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the abdomen.
On admission, routine blood tests revealed white blood cells, 
19,400/µL; hemoglobin, 14.4 g/dL; erythrocyte sedimentation 
rate, 17 mm/hour; platelets, 241,000/µL; neutrophils, 90.8%; 
lymphocytes, 3.7%; monocytes, 4.0%; and eosinophils, 1.4%. 
Arterial blood gas analysis performed in room air exhibited pH 
7.45; PaCO2, 31 mmHg; PaO2, 64 mmHg; HCO3, 22.0 mEq/L; 
base excess, -1.4 mEq/L; and oxygen saturation, 93%. Blood 
biochemical tests showed total protein, 5.9 g/dL; albumin, 3.3 
g/dL; aspartate aminotransferase, 17 IU/L; alanine aminotrans-
ferase, 8 IU/L; C-reactive protein, 4.22 mg/dL; total bilirubin, 
1.1 mg/dL; blood urea nitrogen, 4.0 mg/dL; and creatinine, 0.4 
mEq/L. Chest X-ray showed diffuse bilateral infiltrates, espe-
cially in the peripheral region (Fig. 1) and chest CT exhibited 
multiple nodular lesions with ground-glass appearance (Fig. 2). 
The patient was negative for rheumatoid factor, antinuclear an-
tibody, anti-neutrophil cytoplasmic antibody (ANCA), antibody 
against Mycoplasma, and cold agglutinin. The levels of IgG, IgA, 
IgM, complement C3 and C4 were within the normal limits, and 
the total IgE level was 113 KU/L. Cultures of blood and sputum 
were negative for bacteria and fungi. Urine tests were negative 
for antigens of Legionella and Pneumococcus, and IgG tests 
against parasites were negative for Paragonimus westermani 
and Clonorchis sinesis. Stool examination was negative for par-
asite ova. Immediately after admission, ampicillin/sulbactam 
and cefotaxime, as well as oseltamivir, were administered un-
der the suspicion of pandemic H1N1 infection, but hypoxia, 
dyspnea, and pneumonic infiltration on chest X-ray were ag-
gravated abruptly. Non-invasive ventilation was maintained. 
On the second day in hospital, bronchoscopy revealed no ab-
normal findings, but BALF tests exhibited white blood cells, 
280/µL; macrophages, 19%; neutrophils, 10%; lymphocytes, 
26% eosinophils, 35% (eosinophilia); and basophils, 4% (Fig. 
3A). BALF cultures were negative for bacteria and fungi. The 
patient was negative for PCR and culture of viruses, including 
respiratory syncytial virus, influenza virus, parainfluenza virus, 
adenovirus, and human metapneumovirus; real-time RT-PCR 
for the novel influenza virus H1N1; antigen tests for Aspergillus 
Fig. 1.  Serial chest X-ray on admission, hospital days 5, 6 and 7 showing dramatic improvement after the initiation of corticosteroids on hospital day 5.
Fig. 2.  Chest CT on admission (A) and follow-up after 2 months (B) reveals markedly improved ground glass opacity and air space consolidation in both lungs.
A BAllergy Asthma Immunol Res. 2010 April;2(2):144-148.  doi: 10.4168/aair.2010.2.2.144
Youn et al. Volume 2, Number 2, April 2010
146 http://e-aair.org
and Pneumocystis jiroveci; PCR and culture of cytomegalovirus 
and Chlamydia pneumonia; PCR of Epstein-Barr virus; and ac-
id-fast bacillus smear. On the third day in hospital, thoracosco-
py-assisted lung biopsy was performed in the middle and lower 
lobes of the left lung, which showed eosinophilic infiltrates sug-
gestive of interstitial pneumonia (Fig. 3B). Based on these re-
sults, the patient was diagnosed with acute eosinophilic pneu-
monia. On the fifth day in hospital, urine cotinine level, which 
was determined to confirm smoking, was 47 ng/mL. Further-
more, routine blood test revealed white blood cells, 5,500/µL; 
neutrophils, 45.8%; lymphocytes, 26.0%; monocytes, 9.0%; and 
eosinophils (19.0%, eosinophilia). Methylprednisolone (125 
mg) was administered every 6 hours. The day after methylpred-
nisolone administration, hypoxia and dyspnea improved, and 
infiltrates on chest X-ray improved 2 days after drug adminis-
tration (Fig. 1). Methylprednisolone was tapered from the 
fourth day of drug administration. The patient was discharged 
from the hospital on day 9 and was followed up periodically. At 
the time of discharge from the hospital, routine blood tests re-
vealed white blood cells, 10,300/μL; neutrophils, 59.6%; lym-
phocytes, 31.5%; monocytes, 6.3%; and eosinophils, 2.4% (with-
in the normal limits). There were no specific findings in pulmo-
nary function, methacholine provocation, and skin prick tests. 
Methylprednisolone is being tapered at the outpatient clinic. 
On day 15 of follow-up, chest X-ray showed no infiltrates.
DISCUSSION
Acute eosinophilic pneumonia belongs to the eosinophilic 
lung diseases that are characterized by acute respiratory symp-
toms including fever, cough, dyspnea, diffuse bilateral infiltrates, 
and hypoxia. Eosinophilic lung disease includes a variety of in-
filtrative lung diseases that have marked eosinophilic infiltrates 
into the lung parenchyma, probably caused by eosinophils, and 
was first described by Löffler
7 in 1932. Crofton et al.
8 have clas-
sified this disease entity into five groups: simple pulmonary eo-
sinophilia or Löffler’s syndrome, prolonged pulmonary eosino-
philia, pulmonary eosinophilia with asthma, topical eosinophil-
ia, and pulmonary eosinophilia with polyarteritis nodosa. Car-
rington et al.
9 have described chronic eosinophilic pneumonia 
that is characterized by high fever; night sweating; weight loss; 
respiratory symptoms such as severe dyspnea, diffuse infiltrates, 
and eosinophilia of the lung and peripheral blood; and dramat-
ic responses to steroids, with frequent recurrence after their dis-
continuation. Badesch et al.
1 have described acute eosinophilic 
pneumonia that is similar to chronic eosinophilic pneumonia, 
but different in that it shows symptoms during a period of <1 
month, no association with asthma or other complications, ab-
sence of definite causes, and no recurrence after discontinua-
tion of treatment. Allen et al.
2 have reported four cases of acute 
eosinophilic pneumonia. Recently, eosinophilic lung diseases 
have been classified into three groups: (1) those with determined 
causes, including eosinophilic pneumonia due to parasites and 
other pathogens, drugs, toxins or radiation, as well as allergic 
bronchopulmonary aspergillosis; (2) those with undetermined 
causes, including simple pulmonary eosinophilia, acute eosino-
philic pneumonia, chronic eosinophilic pneumonia, Churg-
Strauss syndrome, and hypereosinophilic syndrome; and (3) 
miscellaneous lung diseases with possible associated eosino-
philia.
5,10
Although the pathophysiology of acute eosinophilic pneumo-
nia has not yet been elucidated, it is thought to be caused by 
acute hypersensitivity to inhaled allergens.
2 Most cases are idio-
pathic, but a few cases seem to be associated with recent smok-
Fig. 3.  (A) Bronchoalveolar lavage fluid shows more than 25% eosinophils (Wright stain, ×400). (B) Lung biopsy specimen on the third day shows that many inflam-
matory cells are present in the alveolar spaces and septae, which are admixed with fibrous exudates. The majority of the infiltrated cells are eosinophils (Hematoxy-
lin-eosin stain, ×400).
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ing or nonspecific dust inhalation.
11 Cases of acute eosinophilic 
pneumonia have continually been reported in new young smok-
ers. When smokers continue to smoke, they may develop toler-
ance, but acute eosinophilic pneumonia can develop in current 
smokers who increase their amount of smoking.
4,6,12-17 Subjects 
who restart smoking show clinical symptoms and signs similar 
to those of acute eosinophilic pneumonia.
13-15 Watanabe et al.
13 
have reported that acute eosinophilic pneumonia that is proba-
bly caused by smoking can occur at a mean age of 19 years and 
a mean of 14.3 days after initiation of smoking. It has been re-
ported in United States soldiers that the incidence of acute eo-
sinophilic pneumonia was 9.1 soldiers per 10,000, and that all 
cases of acute eosinophilic pneumonia occurred in smokers, 
78% of whom started smoking within 1 month of its occurrence.
17 
As the incidence of acute eosinophilic pneumonia is low com-
pared to that of smoking, it is difficult to regard smoking as its 
single cause. Our case developed in a girl who started smoking 
(3-5 cigarettes daily) 3 weeks prior to admission. Acute eosino-
philic pneumonia develops most frequently around the age of 
30 years in healthy subjects without a past history of asthma or 
atopy, and more frequently in men.
5,18 Clinical symptoms have 
an acute onset of <7 days, including fever, cough, tachypnea, and 
dyspnea, which may lead to a misdiagnosis of pneumonia.
4,12,19 
Because dyspnea is aggravated rapidly, it is difficult to discrimi-
nate acute eosinophilic pneumonia from acute respiratory dis-
tress syndrome or acute lung injury.
4,12,19 Most patients show a 
fever of more than 38°C, 73% report chest pain, and a few pa-
tients complain of myalgia or abdominal pain. Chest ausculta-
tion reveals crackles in 80% of patients and normal breathing 
sounds in 20%.
4,12,19 Chest X-ray shows reticulonodular density 
in the air spaces or interstitial tissues in both lung fields, especial-
ly peripheral fields, frequently accompanied by small amounts 
of pleural effusion.
4,10,20 Chest CT exhibits bilateral ground-glass 
attenuation, interlobular septal thickening, thickening of bron-
chovascular bundles, bilateral pleural effusion without cardio-
megaly, and random distribution.
10,21 Although the number of 
eosinophils is usually normal at the initial stage, it frequently 
increases over time.
19 The IgE level varies between normal and 
extremely high.
19 The BALF tests are the core measures for the 
diagnosis of acute eosinophilic pneumonia and show that the 
numbers of eosinophils, lymphocytes and neutrophils increase 
by 37-54%, 20%, and 15%, respectively.
4,12 These findings are dif-
ferent from those for chronic eosinophilic pneumonia, which 
show normal cell fractions, except for eosinophils. Acute eosino-
philic pneumonia can be diagnosed presumptively if the pro-
portion of eosinophils in BALF is ≥25%, and it can be diagnosed 
definitively if that value is ≥40%.
18 Although lung biopsy is not 
usually needed to diagnose acute eosinophilic pneumonia, it 
can be used in cases that are difficult to diagnose, such as im-
munodeficiency in which fungal infections cannot be ruled out. 
Pathological examination exhibits eosinophilic infiltrates in the 
interstitial tissue and alveolar space, and diffuse alveolar inju-
ry.
6,10 Pulmonary function tests are not pathognomonic and 
show that about 50% of patients have restrictive patterns and 
the remaining 50% have obstructive patterns.
18
Although our case showed clinical features of acute eosino-
philic pneumonia, such as severe dyspnea, pulmonary infiltrates 
were observed in the bilateral peripheral fields. Broad-spectrum 
antibiotics were administered due to the progression of infiltra-
tion, but the infiltration did not improve. BALF tests revealed an 
increase in eosinophils and other inflammatory cells. In our pa-
tient, differential leukocyte counts of peripheral blood showed 
that eosinophils accounted for 1.4% of the total leukocytes on ad-
mission, but increased to 19% on the fifth day in hospital, which 
suggests that most eosinophils migrated to the lung. We could 
not perform pulmonary function tests because of severe dysp-
nea, but the tests performed 8 days after the initiation of steroid 
administration revealed normal findings.
Our female adolescent patient reported at first that she had 
not smoked. However, when a thorough history was taken un-
der clinical suspicion of acute eosinophilic pneumonia, she re-
ported that she had smoked for 2 weeks and then stopped dur-
ing the week prior to admission. This was thought to be an ado-
lescent case of acute eosinophilic pneumonia that was induced 
by smoking. Recently, the onset of smoking has occurred at a 
younger age, and the incidence has increased.
22 As adolescents 
try to avoid reporting that they smoke, an accurate history of 
smoking is difficult to obtain. Therefore, when smoking habits 
are suspected strongly, physicians should make an effort to take 
a thorough history of smoking. To screen smokers, many tests 
have been used. Among these, measurement of urine cotinine 
concentration is a noninvasive method and yields better results 
than saliva cotinine concentration does. Cotinine has a half-life 
of approximately 19 hours and has high sensitivity, based on the 
response to questionnaires.
23 Much controversy exists regarding 
the cutoff value of cotinine. A previous study with 130 Korean 
high-school students has shown that the mean urine concen-
trations of cotinine were 9.9 and 644.5 ng/mL, respectively, in 
non-smokers and subjective smokers during the previous month 
and that urine cotinine concentration became higher as the fre-
quency of smoking increased.
23 Our patient showed a urine co-
tinine concentration of 47 ng/mL, which was not significantly 
high. This result may be due to the following reasons: (1) the half-
life of cotinine is 19 hours; (2) the patient stopped smoking the 
week before admission; and (3) the test was performed on day 
5 in hospital. Therefore, follow-up with urine cotinine concen-
tration will help detect smoking in adolescent patients.
Acute eosinophilic pneumonia should be discriminated from 
clinically similar lung diseases, especially pulmonary infections. 
In our case, laboratory tests for parasites, viruses, bacteria, and 
fungi were negative. Drugs were excluded as a cause of acute 
eosinophilic pneumonia, and the possibility of connective tis-
sue diseases was judged to be low from the tests. Churg-Strauss 
syndrome was ruled out based on the absence of extrapulmo-Allergy Asthma Immunol Res. 2010 April;2(2):144-148.  doi: 10.4168/aair.2010.2.2.144
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nary symptoms and negativity for ANCA. Other allergic diseas-
es or allergic bronchopulmonary aspergillosis were ruled out 
based on the absence of a previous history of bronchial asthma 
and negative skin reactions to offending allergens. Acute eosino-
philic pneumonia rather than chronic eosinophilic pneumonia 
was suggested based on the following findings: (1) absence of a 
previous history of bronchial asthma; (2) onset at young age; (3) 
abrupt onset of respiratory symptoms; (4) no eosinophilia in 
peripheral blood; and (5) an increased proportion of eosino-
phils, lymphocytes, and neutrophils in BALF.
Because two-thirds of patients with acute eosinophilic pneu-
monia have respiratory failure that requires mechanical ventila-
tion, early diagnosis and appropriate treatment are mandatory.
6 
Steroid administration markedly improves clinical symptoms 
within 24-48 hours.
6 Spontaneous improvement has been re-
ported in a few cases of acute eosinophilic pneumonia.
12,24 In 
cases of respiratory failure, methylprednisolone (60-125 mg) is 
administered every 6 hours until respiratory failure improves, 
and thereafter, oral prednisolone (40-60 mg/day) is adminis-
tered and tapered progressively.
6,25 In a previous study, methyl-
prednisolone (2 mg/kg) was administered every 6 hours to pe-
diatric patients.
26 Steroid dosage must be decided by consider-
ing the patient’s body weight. Most patients with acute eosino-
philic pneumonia can be treated successfully with steroid ther-
apy for 2-12 weeks, without recurrence or sequalae.
6
We experienced the case of a 15-year-old girl who had acute 
eosinophilic pneumonia due to the onset of smoking 3 weeks 
prior to admission. She was diagnosed based on BALF tests/lung 
biopsy and was treated successfully with steroids. A history of 
smoking should be taken in adolescent patients. To exclude the 
possibility of chronic eosinophilic pneumonia, identification of 
recurrence after discontinuation of steroid therapy is needed 
through long-term follow-up.
REFERENCES
Badesch DB, King TE Jr, Schwarz MI. Acute eosinophilic pneumo- 1. 
nia: a hypersensitivity phenomenon? Am Rev Respir Dis 1989;139: 
249-52.
Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneu- 2. 
monia as a reversible cause of noninfectious respiratory failure. N 
Engl J Med 1989;321:569-74.
Oermann CM, Panesar KS, Langston C, Larsen GL, Menendez AA,  3. 
Schofield DE, Cosio C, Fan LL. Pulmonary infiltrates with eosino-
philia syndromes in children. J Pediatr 2000;136:351-8.
Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN.  4. 
Acute eosinophilic pneumonia. A summary of 15 cases and review 
of the literature. Medicine (Baltimore) 1996;75:334-42.
Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy 2005;60:841- 5. 
57.
Son C. Eosinophilic pneumonia. Tuberc Respir Dis 2008;64:177- 6. 
86. Korean.
Löffler W. Zur differential-diagnose der lungeninfiltrierungen. Il  7. 
uber fluchtige succedan-infiltrate (mit eosinophilie). Beitr Klin Tu-
berk 1932;79:368-92.
Crofton JW, Livingstone JL, Oswald NC, Roberts AT. Pulmonary eo- 8. 
sinophilia. Thorax 1952;7:1-35.
Carrington CB, Addington WW, Goff AM, Madoff IM, Marks A,  9. 
Schwaber JR, Gaensler EA. Chronic eosinophilic pneumonia. N 
Engl J Med 1969;280:787-98.
Jeong YJ, Kim KI, Seo IJ, Lee CH, Lee KN, Kim KN, Kim JS, Kwon WJ.  10. 
Eosinophilic lung diseases: a clinical, radiologic, and pathologic 
overview. Radiographics 2007;27:617-37; discussion 37-9.
Rom WN, Weiden M, Garcia R, Yie TA, Vathesatogkit P, Tse DB,  11. 
McGuinness G, Roggli V, Prezant D. Acute eosinophilic pneumo-
nia in a New York City firefighter exposed to World Trade Center 
dust. Am J Respir Crit Care Med 2002;166:797-800.
Philit F, Etienne-Mastroianni B, Parrot A, Guerin C, Robert D, Cordi- 12. 
er JF. Idiopathic acute eosinophilic pneumonia: a study of 22 pa-
tients. Am J Respir Crit Care Med 2002;166:1235-9.
Watanabe K, Fujimura M, Kasahara K, Yasui M, Myou S, Kita T,  13. 
Watanabe A, Nakao S. Acute eosinophilic pneumonia following 
cigarette smoking: a case report including cigarette-smoking chal-
lenge test. Intern Med 2002;41:1016-20.
Shintani H, Fujimura M, Ishiura Y, Noto M. A case of cigarette smok- 14. 
ing-induced acute eosinophilic pneumonia showing tolerance. 
Chest 2000;117:277-9.
Shin JH, Kwon YE, Yoon SH, Lee SI. Two cases of cigarette smok- 15. 
ing-induced acute eosinophilic pneumonia. J Asthma Allergy Clin 
Immunol 2007;27:277-82. Korean.
Uchiyama H, Suda T, Nakamura Y, Shirai M, Gemma H, Shirai T,  16. 
Toyoshima M, Imokawa S, Yasuda K, Ida M, Nakano Y, Inui N, Sato 
J, Hayakawa H, Chida K. Alterations in smoking habits are associat-
ed with acute eosinophilic pneumonia. Chest 2008;133:1174-80.
Shorr AF, Scoville SL, Cersovsky SB, Shanks GD, Ockenhouse CF,  17. 
Smoak BL, Carr WW, Petruccelli BP. Acute eosinophilic pneumo-
nia among US Military personnel deployed in or near Iraq. JAMA 
2004;292:2997-3005.
Yong SJ. Diagnosis of eosinophilic lung disease. Tuberc Respir Dis  18. 
2008;64:75-9. Korean.
Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med  19. 
2006;27:142-7.
King MA, Pope-Harman AL, Allen JN, Christoforidis GA, Christo- 20. 
foridis AJ. Acute eosinophilic pneumonia: radiologic and clinical 
features. Radiology 1997;203:715-9.
Daimon T, Johkoh T, Sumikawa H, Honda O, Fujimoto K, Koga T,  21. 
Arakawa H, Yanagawa M, Inoue A, Mihara N, Tomiyama N, Naka-
mura H, Sugiyama Y. Acute eosinophilic pneumonia: Thin-section 
CT findings in 29 patients. Eur J Radiol 2008;65:462-7.
Korea Center for Disease Control and Prevention (KCDC). Results  22. 
of Korea youth risk behavior web-based survey (KYRBWS). 2006. 
Available from: http://healthy1318.cdc.go.kr/
Park SW, Kim JY. Validity of self-reported smoking using urinary  23. 
cotinine among vocational high school students. J Prev Med Public 
Health 2009;42:223-30.
Hayakawa H, Sato A, Toyoshima M, Imokawa S, Taniguchi M. A clin- 24. 
ical study of idiopathic eosinophilic pneumonia. Chest 1994;105: 
1462-6.
Jantz MA, Sahn SA. Corticosteroids in acute respiratory failure. Am  25. 
J Respir Crit Care Med 1999;160:1079-100.
Buchheit J, Eid N, Rodgers G Jr, Feger T, Yakoub O. Acute eosino- 26. 
philic pneumonia with respiratory failure: a new syndrome? Am 
Rev Respir Dis 1992;145:716-8.